TB-500: the thymosin beta-4 fragment and what the research covers

TB-500 is a synthetic peptide built on the active region of thymosin beta-4, used in controlled experiments that zero in on actin binding, cell migration and cytoskeletal organization. Think of it as a research analog for studying how thymosin-beta-4-related sequences influence the structural and motility-linked machinery of a cell.

For laboratory research only. TB-500 is sold strictly for in-vitro laboratory research. It has not been evaluated by the FDA, nothing here covers dosing, administration, or use in people or animals, and no therapeutic claim is made.

Why TB-500 isn't thymosin beta-4

This is the point most sources gloss over, and it matters for anyone reading the literature.

Thymosin beta-4 (Tβ4) is a naturally occurring 43-amino-acid protein, one of the most abundant intracellular proteins in many cell types, and the main G-actin sequestering molecule in mammalian cells. It has a large published literature all its own.

TB-500 is a shorter synthetic sequence taken from the active region of that protein: the actin-binding stretch rather than the entire molecule.

Here's the practical fallout: a paper on thymosin beta-4 is not automatically a paper on TB-500. Much of the secondary writing about TB-500 cites Tβ4 research straight, as if the fragment and the full protein were one and the same. They're related, but they aren't identical: the full protein carries functions and interaction surfaces the fragment lacks, so findings don't cross over without argument. When you chase a TB-500 claim back to its source, check which molecule the study actually used.

Sorting out the names: TB-500, TB500, Tβ4

The naming here is unusually messy, and the variants don't all point at the same thing.

The first row is harmless: TB-500 and TB500 are one material, and suppliers list both spellings. The second row is where mistakes creep in, because Tβ4 and TB-500 get treated as interchangeable when they aren't. A product listed as "thymosin beta-4" at research-peptide pricing is almost certainly the synthetic fragment, not the recombinant full-length protein, which costs considerably more. When the distinction matters to your protocol, the certificate settles it, not the product name.

The actin story

Both molecules draw research interest for one reason: actin.

Actin lives in two states, free monomers (G-actin) and polymerized filaments (F-actin), and the balance between them governs cell shape, movement and structural reorganization. Thymosin beta-4 binds G-actin monomers and holds them in a sequestered pool, controlling how much monomer is free to polymerize. In effect, it buffers the assembly reaction.

Sequences drawn from its actin-binding region are therefore studied as tools for tipping that balance in an experiment. The questions are about cytoskeletal dynamics: how cells rearrange their internal scaffolding, how they migrate, and how those processes are regulated. The responses swing a lot with peptide concentration, exposure time, cell type and study design, which is why concentration is never an afterthought when you compare two results.

What researchers look at

In biochemical and cell-based systems, thymosin-beta-4-derived peptides are assessed for their ability to interact with G-actin, feeding into actin polymerization and wider cytoskeletal remodeling. Typical applications include:

• Probing actin dynamics and cytoskeletal regulation
• In-vitro studies of cell migration and structural organization
• Models looking at tissue architecture and repair-related signaling pathways

As with the fragment-versus-protein point above, most of this literature rests on Tβ4 rather than TB-500 specifically. That's worth knowing before you design a protocol around it.

Why TB-500 and BPC-157 get paired

These two are studied together more than almost any other combination in this catalog, and the logic is that their mechanisms don't overlap.

BPC-157 is a synthetic pentadecapeptide used as a probe for peptide-mediated signaling. TB-500 works on the actin cytoskeleton. So a model examining structural reorganization can probe a signaling arm and a cytoskeletal arm in the same system without the two mechanisms muddying each other; that's the experimental reason the pairing recurs, not any established additive effect.

Side by side:

We supply the pair as the Wolverine Stack, and both sit in the four-part Klow Stack alongside GHK-Cu and KPV. The BPC-157 vs TB-500 comparison lays the two out side by side in more depth, and the BPC-157 guide covers that compound on its own.

One caution on the pairing: because the two are almost always sold and discussed together, plenty of writing pins results on "BPC-157 and TB-500" as a single unit. A combined preparation can't tell you which component did what; that needs the compounds run separately, which is why we offer both individually as well as blended.

What the skeptics say

TB-500 attracts critical commentary as well as promotional copy, and a researcher should read both.

The substantive objections are consistent: the direct evidence base for the fragment is much thinner than for the full protein; much of the enthusiasm traces back to preclinical and animal work that hasn't translated; and material sold online varies in provenance, which makes independent replication hard. Those are fair points, and they're exactly why batch documentation matters more here than for a better-characterized compound.

None of that makes it dull as a research tool. It does mean any claim about what TB-500 achieves should be traced to a source that used TB-500, at a stated concentration, in a stated model.

Where it stands in competitive sport

This belongs on the page, and most seller pages skip it.

Thymosin beta-4 and its related fragments sit on the World Anti-Doping Agency Prohibited List, in the peptide hormones, growth factors and related substances category, banned at all times rather than in competition only. National anti-doping bodies, USADA included, publish on it directly.

If you're a competing athlete, or you work with them, this is not a gray area, and the current WADA Prohibited List, revised every year, is the authority to check, not any supplier page, this one included.

Worth repeating: our material is supplied for in-vitro laboratory research and is not for human use in any setting, competitive or otherwise.

Storage and stability

TB-500 is a peptide and acts like one: temperature-sensitive, degraded by repeated freeze-thaw cycles, and happiest kept cold and kept that way.

Ours ships as a ready-mixed solution rather than a lyophilized powder, which cuts out the reconstitution step where most avoidable variability sneaks in: water choice, added volume, mixing and the wait before first use all vary bench to bench. Store refrigerated at 2-8°C. The peptide calculator handles the concentration math from the vial.

On dosing

We publish no dosing, reconstitution-for-use or administration guidance for TB-500. It's supplied strictly for in-vitro laboratory research and isn't for use in humans or animals, so quantity guidance aimed at a person would be at odds with what's actually supplied. Experimental concentrations are specific to the model and endpoint, and they belong in the primary literature.

Supply and documentation

TB-500 ships as a ready-mixed solution with a batch-specific Certificate of Analysis recording measured purity for the lot you receive, dispatched under cold-chain handling and stored refrigerated at 2-8°C. Recent certificates can be viewed in the COA library before you order.

It's also part of the Wolverine Stack, paired with BPC-157, and of the Glow Stack and Klow Stack. For supply details and available strengths, see the TB-500 product page.

How it ships in the US

For US laboratories, TB-500 is supplied pre-mixed as a solution rather than a lyophilized powder, prepared under controlled conditions and HPLC-verified, with a batch-specific Certificate of Analysis reporting HPLC for purity and mass spectrometry for identity. Every batch is synthesized in our own UK laboratory rather than imported and repackaged, and each lot bound for the United States is checked in a US laboratory before it leaves the warehouse. Orders are dispatched cold-chain from the facility that serves the United States, with tracked delivery across the country next business day, priced in US dollars and payable by Visa, Mastercard or Apple Pay. Store refrigerated at 2-8°C on arrival, not frozen. Recent certificates for the material sit in the COA library.

Related reading

• What is the Wolverine Stack?
• What is BPC-157?
• BPC-157 vs TB-500